Paradoxical Emergence of Cutaneous Squamous Cell Carcinoma During Pembrolizumab Treatment for Non-muscle Invasive Bladder Cancer and Subsequent Successful Therapeutic Adjustments.
Paradoxical Emergence of Cutaneous Squamous Cell Carcinoma During Pembrolizumab Treatment for Non-muscle Invasive Bladder Cancer and Subsequent Successful Therapeutic Adjustments. Cureus. 2025 Mar; 17(3):e80293.